论文信息 - Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69) - 字舞流文

Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)

A. Schneeweiss | C. Denkert | S. Loibl | M. Untch | V. Nekljudova | J. Blohmer | S. Kümmel | J. Furlanetto | C. Jackisch | C. Hanusch | S. Costa | S. Paepke | B. Gerber | G. Minckwitz | M. Warm | M. Clemens | S. Schmatloch | B. Aktas | J. Hackmann | M. Just | H. Wiebringhaus | Sabine Schmatloch